Bovex 2.265% w/v Oral Suspension for Cattle and Sheep

Care must be taken not to damage the pharyngeal region when dosing, particularly
in sheep.
Intensive use or misuse of anthelmintics can give rise to resistance. To reduce this
risk, dosing programmes should be discussed with a veterinary surgeon.
Care should be taken to avoid the following practices because they increase the
risk of development of resistance and could ultimately result in ineffective therapy
•
extended period of time.
•
misadministration of the product, or lack of calibration of the dosing device (if any).
Suspected clinical cases of resistance to anthelmintics should be further
investigated using appropriate tests (e.g., Faecal Egg Count Reduction Test).
Where the results of the test(s) strongly suggest resistance to a particular
anthelmintic, an anthelmintic belonging to another pharmacological class and
having a different mode of action should be used.
Resistance to benzimidazoles (which include oxfendazole) has been reported in
Teladorsagia, Haemonchus, Cooperia and Trichostrongylus species in small
ruminants in a number of countries, including the EU. Resistance to albendazole
has been reported in Cooperia and Teladorsagia species in cattle in developed
countries such as New Zealand. Therefore, the use of this product should be based
on local (regional, farm) epidemiological information about susceptibility of
nematodes and recommendations on how to limit further selsction for resistance to
anthelmintics.

i. Special precautions for use in animals
Assess bodyweight as accurately as possible before calculating the dosage.
ii. Special precautions for the person administering the veterinary medicinal
product to animals
Avoid contact with the skin and eyes. Wash any splashes immediately with cold
water. Wear suitable protective clothing including impermeable rubber gloves.
Wash hands after use.

Amended pages: November 2025
AN: 01686/2025